ORAL CANCER: LYMPHO DISSECTION AT CN0 AND CN+ Tekijä Sh. I. Musin

Hae kokoteksti

PERIOPERATIVE ASSESSMENT OF CHEMILUMINESCENCE INDICATORS OF LYMPH NODES IN TONGUE CANCER Tekijä Sh. I. Musin, R. R. Farkhutdinov

Hae kokoteksti

Predictors of Multiple Primary Malignancies: Literature Review Tekijä A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva

Hae kokoteksti

Features of the Course of Radioinduced Breast Cancer. Clinical Observation Tekijä M. M. Zamilov, K. V. Menshikov, Sh. I. Musin, A. V. Sultanbaev, G. I. Zamilova, A. H. Nguyen

Hae kokoteksti

Hedgehog inhibitor in the treatment of basal cell skin cancer: case report Tekijä Sh. I. Musin, N. А. Sharafutdinova, A. V. Sultanbaev, S. V. Osokin, B. A. Ibragimov, K. V. Menshikov, R. T. Ayupov

Hae kokoteksti

Clinical case of the treatment of metastatic luminal breast cancer Tekijä A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov

Hae kokoteksti

A biopsy of the signaling lymph node in case of early oral cancer (cT1–2N0M0) by the lymphoscintigraphic method: one center study Tekijä Sh. I. Musin, S. V. Osokin, Т. G. Yatsenko, A. V. Sultanbaev, М. М. Zamilov, М. М. Vakhito, V. V. Ilyin

Hae kokoteksti

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice Tekijä A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov

Hae kokoteksti

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer Tekijä A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev

Hae kokoteksti

Neuroendocrine Tumours: a Literature Review Tekijä K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov

Hae kokoteksti

Combined Use of Cabozantinib and Nivolumab in Clinical Practice Tekijä V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova

Hae kokoteksti

Metastatic renal cell carcinoma, the possibility of targeted therapy. Case. Tekijä K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov

Hae kokoteksti

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency Tekijä R. T. Ayupov, A. A. Izmailov, K. V. Menshikov, A. V. Sultanbaev, A. F. Nasretdinov, R. R. Rakhimov, Sh. I. Musin, N. I. Sultanbaeva

Hae kokoteksti

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) Tekijä K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Hae kokoteksti

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review Tekijä K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, L. A. Khammatova

Hae kokoteksti

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice Tekijä G. A. Serebrennikov, К. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov, A. Sh. Rezyapova

Hae kokoteksti

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review Tekijä K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova

Hae kokoteksti

Efficacy of the 1^st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens Tekijä K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov

Hae kokoteksti

Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results Tekijä Sh. I. Musin, A. V. Sultanbayev, K. V. Menshikov, F. F. Mufazalov, A. F. Nasretdinov, O. V. Goncharova, S. V. Osokin, M. M. Zamilov, K. E. Timin

Hae kokoteksti

Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case Tekijä A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva

Hae kokoteksti